Scanning electron microscopy and dynamic light scattering revealed that the particles are spherical in shape, have a size distribution between 220 and 840 nm of diameter, and have a tendency to aggregate confirmed by a zeta potential between -3.2 and +3.5 mV. Using this method the loading efficiency was 26% for trans-[Ru(NO)Cl(cyclam)](PF6)(2) and 32% for [Ru(NO)(Hedta)]. The release of the complexes from the NPs shows that cyclam-NP and Hedta-NP exhibited a two-phase exponential association release pattern, which was characterized by an initial complex burst during the first 24 h, followed by a slower release phase complex profile, due to a few pores observed in surface

of nanoparticles using atomic force microscopy. The in vitro cytotoxic activity of the nitrosyl complexes in solution and incorporated buy CHIR-99021 in PLGA nanoparticles on melanoma cancer cells (cell line B16-F10) was investigated. The lower cytotoxicity of trans-[RuCl(cyclam)(NO)](2+) (12.4 +/- 2.6%) and [Ru(NO)(Hedta)] (4.0 +/- 2.7%) in solution compared to that of trans-[Ru(NO)(NH3)(4)py](3+) (46.1 +/- 6.4%) is consistent with

the rate constant release of NO of these complexes (k(-NO) = 6.2 x 10(-4) s(-1), 2.0 x 10(-3) s(-1), and 6.0 x 10(-2) s(-1), respectively); the cytotoxicities are also inhibited in the presence of the NO Selleck AG-881 scavenger carboxy-PTIO. The phototoxicity of these complexes is due to NO release, which lead to 53.8 +/- 6.2% of cell death in the. presence of trans-[Ru(NO)Cl(cyclam)](PF6)(2) and 22.3 +/- 5.1% in the presence of [Ru(NO)(Hedta)]. The PLGA nanoparticles loaded with trans-[Ru(NO)Cl(cyclam)](PF6)(2) and [Ru(NO)(Hedta)] exerted in vitro a reduced activity against melanoma cells when compared to the activity of complex in solution (nonentrapped in nanoparticles). Blank PLGA nanoparticles did not exhibit cytotoxicity. In the presence of light and of ruthenium nitrosyl complexes or cyclam-NP and Hedta-NP, B16-F10 cells displayed a considerable

damage of the surface with rupture of the plasma Fosbretabulin membrane. This behavior is an indicative of the efficiency of the DDS to deliver the NO from the entrapped complex when photoinduced.”
“OBJECTIVE To review our experiences with management of symptomatic ureteral calculi complicating pregnancy.\n\nMETHODS Between January 2001 and December 2011, 57 pregnant women were treated for symptomatic ureteral stones. The medical records of these patients were reviewed retrospectively.\n\nRESULTS The mean patient age was 24 (range 17-37) years and gestational age at presentation was 26 weeks (range 12-38). Most of the cases (60%) occurred in the third trimester. Flank pain was the most common presenting symptom (90%). Ultrasonography was the initial test confirming diagnosis. With conservative management, spontaneous passing of stones was noted in 13 cases (22.8%). In 10 patients (17.5%), symptomatic relief occurred without spontaneous passing of stones until the end of pregnancy.